Amongst the other tips with the WHO, there was the proposed addition of the footnote on the Routine I part in the Conference, stating that preparations that contains predominantly cannabidiol rather than greater than 0.2 for each cent of delta-9-tetrahydrocannabinol are usually not beneath Intercontinental Management.[35] Nevertheless, the proposal